Client News

Andera Partners supports TargED Biopharmaceuticals in €39 million Series A financing to bring groundbreaking thrombolytic treatment to patients

Secarna Pharmaceuticals’ partner Denali Therapeutics exercises option for LNAplusTM antisense oligonucleotide development program in neurodegeneration

InflaRx Reports Progress in Ongoing Phase II Clinical Trial with Vilobelimab in Cutaneous Squamous Cell Carcinoma

Topas Therapeutics Appoints Cristina de Min, M.D. as Chief Medical Officer

Marinomed receives € 6 m with final tranche of financing agreement with EIB to invest in proprietary R&D pipeline

AiCuris and Hybridize Therapeutics enter worldwide license agreement of up to €100M for a direct-acting RNA-based therapy against BK Virus

Lindis Blood Care successfully closes follow-on financing round

Abivax to host Satellite Symposium at the 17th Congress of ECCO on Feb. 17, 2022

Destiny Pharma: Positive feedback from European Medicines Agency on XF-73 Nasal gel Phase 3 programme

InflaRx to Present at Annual SVB Leerink Global Health Conference